Israel
DrugsIntel is an Israeli-based startup founded in 2019 that offers data-driven solutions to healthcare organizations. The company's technological platform aggregates unique data sets and applies manipulation, unification, and deployment of the data to a BI, AI, and ML platform. This allows for the identification and prediction of drug shortages globally, monitoring, sourcing, and cross-matching products to address unmet medical needs. The company's vision is based on Dr. Shlomo Sadoun’s thesis, "Six pillar of successful launches of orphan drugs globally," utilizing cutting-edge technologies to support smart business decisions and better healthcare solutions.
DrugsIntel's unique platform allows for the extraction of all relevant data, the collection of historical data and risk factors, and the monitoring of markets to collect real-time intelligence and rare diseases data. The company focuses on making data-driven decisions and creating business opportunities. The essence of the company is to guide orphan drugs companies towards an excellent launch of their drugs, based on the orphan drug 6 pillars of success methodology. The Compass, DrugsIntel's solution, provides an eagle eye view of the orphan drug market opportunities in 65 countries and counting, with a mission of answering unmet needs for patients and their caregivers dealing with rare diseases.
DrugsIntel operates in the enterprise software and information technology industries, positioning itself as a promising player in the healthcare data solutions market. With its innovative approach and focus on leveraging advanced technologies for better healthcare outcomes, DrugsIntel presents an intriguing opportunity for potential investors seeking to support impactful and cutting-edge healthcare solutions. Although specific investment details are not available, the unique positioning and vision of DrugsIntel make it a startup to watch in the evolving landscape of healthcare technology.
